A Study of the Effect of Ezetimibe on Glucose Metabolism in Type 2 Diabetics With Hypercholesterolemia (P06541)

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 152 participants.

Also called NCT01611883

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 152 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01611883
Main results
  • A randomized, double-blind, placebo-controlled study of the effect of ezetimibe on glucose metabolism in subjects with type 2 diabetes mellitus and hypercholesterolemia Lipids in health and disease, 2015-05-01 DOI, PubMed 25929253, PMC4450465 In the PMC Open Access subset under CC BY.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
Not reported
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01611883. Randomized; double masking; primary purpose treatment. Start 2012-07-02 (actual); primary completion 2014-01-16 (actual). Results posted on 2014-12-17.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Study of the Effect of Ezetimibe on Glucose Metabolism in Type 2 Diabetics With Hypercholesterolemia (P06541)
Condition
Hypercholesterolemia
Intervention (Drug)
Ezetimibe
Intervention (Drug)
Placebo
Lead sponsor
Organon and Co (class: industry)

Record details

Record id
cardio:ct-nct01611883
Content hash
1f9c57c746da20be2403868e0ef90f01ae20ff8b11b10d3f02c4189fe1aed8f4